FacebookTwitterLinkedInContact UsLabrix.com

Advanced Workshop

Las Vegas, NV: February 9-11, 2018

Early Bird Discount: Save $50

Interested in gaining a deeper understanding of how hormone and neurotransmitter imbalances are affecting your patient’s health? Register now for the Labrix Advanced Workshop to secure your seat and your Early Bird offer! Includes a Free NeuroAdrenal Panel (Value $215).

 

Core Training

Core Training is designed for practitioners who are new to the field of neuroendrocrine testing and optimization, including BHRT, or are new to using Labrix. Registration for next year's core events will be made available soon. Click here for more information.

 

Wellness Wednesday

Webinar Series

Topic: Comprehensive Hormone Health for Women

January 3, 2018

Join Labrix clinical staff and special guests on the first Wednesday of every month at 9:30 AM and 12:00 PM PST. This free, live webinar series will cover a variety of neuroendocrine topics that will enhance your knowledge, with clinically applicable testing and treatment considerations.

 

To Pee or Not to Pee?

 

Published on 12/27/17

Practitioners with a keen eye may have recently noticed a change within our NT collection guidelines allowing practitioners/patients the option of either a first or second morning urine void. What’s the deal?

Within the field of integrative medicine, the second morning void of urine has been the standard collection method for testing urinary neurotransmitters. However, new study has revealed that the first and second morning voids should provide both accurate and equivocal urinary neurotransmitter levels if fasting, exercise avoidance, and stress-control are maintained until the second morning void.

This is great news for practitioners testing children and adults who have difficulty continuing to fast until the second urine void of the day. Additionally, patients experiencing stressful morning schedules due to family matters, commuting, or strenuous exercise may want to consider choosing a first AM void, avoiding potential impact to the catecholamine levels in a second morning void.

Health care providers may now choose whichever collection time best fits the patient’s unique situation. It is recommended to be consistent in collection times with follow-up testing. Also, ensure the requisition form indicates which void was collected, as this information is valuable during laboratory analysis and for reference when comparing future test results. 

We are happy to bring this new information to our providers, as ease of collection is essential to the success of integrative practitioners seeking true and lasting healing for their patients.

 

References

Grebe S, Singh R. LC-MS/MS in the clinical laboratory –where to from here? Clin Biochem Rev2011 Feb;(32):5–31.

Katayev A, Balciza C, Seccombe DW. Establishing reference intervals for clinical laboratory test results: is there a better way? Am J Clin Pathol. 2010;133(2):180–186.

Marc DT, Ailts JW, Campeau DCA, Bull MJ, Olson KL. Neurotransmitters excreted in the urine as biomarkers of nervous system activity: Validity and clinical applicability. Neurosci Biobehav Rev. 2011;35(3):635–644.

Mayo Foundation for Medical Education and Research [website]. Catecholamine fractionation, free, 24 hour, urine 5-hydroxyindoleacetic acid (5-HIAA), 24 hour, urine. http://www.mayomedicallaboratories.com/index.html. Accessed 15 June 2015.

Paul SM. GABA and glycine. In: Davis KL, Charney D, Coyle J, Nemeroff C, eds. Neuropsychopharmacology: The Fifth Generation of Progress. Philadelphia: Lippincott, Williams, & Wilkins; 2002.

Tsunoda M. Recent advances in methods for the analysis of catecholamines and their metabolites. Anal Bioanal Chemistry. 2006;386(3):506–514.

Young EA, Breslau N. Cortisol and catecholamines in posttraumatic stress disorder: an epidemiologic community study. Arch Gen Psychiatr. 2004;61(4):394–401.

 

Labrix Live Trainings

Join the hundreds of practitioners who have attended Labrix live training events and learn more about these exciting opportunities directly from a Labrix attendee and Dr. Jay Mead, Medical Director and co-founder of Labrix.